Get Your Personalized Supplement StackSupplement Stack Quiz

Saccharomyces Exiguus

Also known as: Saccharomyces exiguus

Overview

*Saccharomyces exiguus* is a species of yeast belonging to the *Saccharomyces* genus, which also includes more well-known species like *S. cerevisiae* and *S. boulardii*. It is naturally found in environments such as soil and plant surfaces. Unlike its relatives, *S. exiguus* has not been extensively studied for its probiotic potential or use as a human supplement. Research has primarily focused on its genetic characteristics and ecological roles, particularly in agricultural contexts. Studies suggest it may play a role in plant growth promotion and nutrient uptake when used as a soil inoculant. However, there is a significant lack of clinical trials or systematic reviews investigating its effects on human health. Its distinct genetic and mitochondrial characteristics differentiate it from other *Saccharomyces* species, but its potential benefits and risks for human consumption remain largely unknown. Given the limited research, caution is advised regarding its use as a supplement.

Benefits

Currently, there is insufficient evidence to support any specific health benefits of *Saccharomyces exiguus* in humans. While some studies suggest it can enhance plant growth and nutrient uptake in agricultural settings, these findings do not translate directly to human health benefits. No clinical trials or systematic reviews have investigated the effects of *S. exiguus* supplementation on human health outcomes. Therefore, no specific benefits can be identified for any particular population, and there are no available data on effect sizes or clinical significance.

How it works

The mechanisms of action of *Saccharomyces exiguus* are not well-understood in the context of human health. In agricultural settings, it may interact with soil bacteria to enhance nutrient solubilization and plant growth. However, there is no evidence describing how *S. exiguus* interacts with human body systems, and no molecular targets have been identified in human health contexts. Data on the absorption and bioavailability of *S. exiguus* when used as a supplement are also lacking.

Side effects

Due to the limited research on *Saccharomyces exiguus* as a human supplement, there is insufficient data to assess its safety profile. No common, uncommon, or rare side effects have been reported. There is also no available data on potential drug interactions, contraindications, or special population considerations. Given the absence of safety data, caution is advised, and it is not recommended to use *S. exiguus* as a supplement without further rigorous scientific investigation.

Dosage

There are no established dosing guidelines for *Saccharomyces exiguus* as a supplement due to the lack of relevant studies. The minimum effective dose, optimal dosage ranges, and maximum safe dose have not been determined. Timing considerations, form-specific recommendations, absorption factors, and required cofactors are also not applicable at this time.

FAQs

Is *Saccharomyces exiguus* safe to take as a supplement?

There is not enough research to determine if *S. exiguus* is safe for human consumption. No safety data is available, so caution is advised.

What are the potential benefits of taking *Saccharomyces exiguus*?

There is currently no evidence to support any health benefits of *S. exiguus* in humans. Studies have focused on its agricultural applications, not human health.

How should *Saccharomyces exiguus* be taken?

There is no practical usage guidance available for *S. exiguus* as a supplement due to the lack of relevant studies. Dosing and timing are not established.

Are there any known risks associated with *Saccharomyces exiguus*?

Given the absence of safety data, it is not possible to determine the risks associated with *S. exiguus*. Further research is needed to assess its safety profile.

Research Sources

https://www.microbiologyresearch.org/content/journal/ijsem/10.1099/00207713-48-3-1015 – This study examined the genetic stability and mitochondrial genomes of various *Saccharomyces* species, including *S. exiguus*. It highlighted the distinct genetic characteristics of *S. exiguus* compared to other species within the genus. The research focused on genetic and evolutionary aspects rather than its potential use as a supplement.
https://www.mdpi.com/2223-7747/12/3/681 – This study found that co-inoculation of soybeans with *Bradyrhizobium japonicum* and *S. exiguus* enhanced plant growth and nutrient uptake. The research suggests a potential role for *S. exiguus* in agricultural applications. However, this study is not relevant to human health benefits or its use as a supplement.
https://www.wjgnet.com/1007-9327/full/v16/i18/2202.htm – This article discusses the role of probiotics in treating Helicobacter pylori infection. While it provides a general overview of probiotic use, it does not specifically address *Saccharomyces exiguus* or its potential benefits. The article focuses on other probiotic strains and their mechanisms of action against H. pylori.
https://pubmed.ncbi.nlm.nih.gov/2673556/ – This study investigates the effect of Saccharomyces cerevisiae var. boulardii on intestinal disaccharidases in rats with experimental short bowel syndrome. While it focuses on another species of Saccharomyces, it provides insights into the potential effects of yeast on intestinal function. The study does not address Saccharomyces exiguus or its specific properties.